The Patient Care Connect Program lowers Medicare costs and provides other benefits, research indicates.
Number of Medicare beneficiaries getting compounded drugs up 281 percent since 2006
A recent study examined the possible correlation between Medicaid coverage status and overall survival for patients with head and neck cancer.
Affordable Care Act Changes in Medicare Drug Coverage May Not Be Enough to Defray the Costs of Oral Cancer TherapiesDecember 23, 2015
Out-of-pocket costs for Medicare beneficiaries taking oral chemotherapy drugs are high, and despite changes in cost sharing due to the Affordable Care Act, those costs will remain high.
In a recent announcement, Medicare stated that it will begin reimbursing doctors who work with patients to plan end-of-life care.
Amgen's Blincyto costs about 178,000 for a standard course of treatment.
Cost of radiotherapy among Medicare patients varied most widely because of year of diagnosis, location of treatment, clinic type, and provider.
The Medicare costs for older patients with oral cavity and pharyngeal cancers have increased due to several factors, including on demographics, treatment selection, and co-existing illnesses.
Higher costs for breast cancer treatments are linked to better outcomes, according to a recent study.
A recent study demonstrates cost efficiencies seen in patients with cancer who enrolled in the Medicare hospice program. It also offers explanations for why more patients may not be using the program.
'Extra Help' program allows more women of varying racial and ethnic backgrounds to continue their hormone therapy.
The pros and cons of low-dose computed tomography (CT) screening for lung cancer are evlauated in relation to the Centers for Medicaid & Medicare Services (CMS) evaluation of screening coverage.
Low-dose computed tomography has been determined to be both an effective and low cost means of detecting lung cancer in Medicare beneficiaries.
Breast cancer screening costs for Medicare patients skyrocketed between 2001 and 2009, but the increase did not lead to earlier detection of new breast cancer cases, according to a study.
A large number of U.S. Senators and Representatives are taking the lead to support full Medicare coverage of low-dose computed tomography screening for seniors at high risk for lung cancer.
Medicare spent at least $1.9 billion in 2009 on 26 types of tests and procedures that offer patients few or no health benefits, according to a new study.
Investment in nursing could reduce Medicare readmissions penalties.
Major news out of the White House: a delay of the Affordable Care Act's employer mandate until January, 2015.
Cutting health care costs by refusing to pay for drugs that do not improve survival or quality of life has the support of the majority of cancer doctors, patients, and members of the general public, according to a new study.
What are the new Medicare guidelines for the administration of an epoetin alfa injection (Procrit) or a darbepoetin alfa injection (Aranesp)?
Fewer Medicare beneficiaries are dying in the setting of acute care hospitals, but health care transitions and intensive care unit utilization are increasing in the last month of life.
U.S. health care could be significantly affected by failure to reach 'fiscal cliff' agreement.
Medicare payment for screening colonoscopy in 2001 linked to decreases in proximal resection.
Medicare coverage of an unproven mammography device has increased usage of the device, according to a study conducted by researchers at the UC Davis Cancer Center.
Changing treatment options for cancer patients has led to an increase in both the use and cost of diagnostic imaging, according to a study published in JAMA (2010;303(16):1625-1631).
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|